gout and tirzepatide Vasso's Corner: Tirzepatide, a new era for dual-treatment for type-2 diabetes obesity Gout and Tirzepatide: What You

A study of nearly 1.8 million adults with diabetes suggests patients with obstructive sleep apnea derive a 20% greater mortality reduction from GLP-1 therapy than those without the sleep disorder

PT-141 (Bremelanotide) The only FDA-approved peptide for hypoactive sexual desire disorder (HSDD) in premenopausal women, also used off-label in menopausal women

A comprehensive 2017 meta-analysis of randomized controlled trials demonstrated that L-carnitine treatment significantly improved left ventricular ejection fraction and cardiac output in patients with chronic heart failure

[PubMed] [Google Scholar] 90.Barabanova S.V., Artyukhina Z.E., Ovchinnikova K.T., Abramova T.V., Kazakova T.B., Khavinson V.K., Malinin V.V., Korneva E.A

As GLP-1 medications gain traction, such collaborations demonstrate how the fitness industry is increasingly addressing weight management through a combination of medical and fitness-based approaches